|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,227.00 DKK | -1.07% |
|
+3.49% | +9.77% |
| 12:38pm | Jyske Bank Raises Genmab Target Price to 2,300 Danish Kroner (2,000), Reiterates Hold - BN | FW |
| 14/01 | Genmab A/S Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 03:45 PM |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 2.16TCr | |||||
| 4.93TCr | |||||
| 4.41TCr | |||||
| 3.49TCr | - | ||||
| 2.74TCr | - | ||||
| 2.12TCr |
- Stock Market
- Equities
- GMAB Stock
- Charts Genmab A/S
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition